278-355-8

Applied Filters:

Keyword:'278-355-8'

Showing 1-2 of 2 results for "278-355-8" within Papers

Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.

Lelia H Chaisson et al.

AIDS (London, England), 33(5), 895-902 (2019-01-17)

In resource-limited settings, mortality in the initial months following antiretroviral therapy (ART) initiation remains unacceptably high. Novel tools to identify patients at highest risk of poor outcomes are needed. We evaluated whether elevated C-reactive protein (CRP) concentrations predict poor outcomes

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients.

Fatemeh Keshavarzi et al.

Familial cancer, 11(1), 57-67 (2011-09-16)

Breast cancer is the most common cancer in Iranian women (Mousavi et al in Asian Pac J Cancer Prev 9(2):275-278, 2008). Genetic predisposition accounts for 15% of all breast cancers and germline mutations in breast cancer susceptibility genes, BRCA1 and

Page 1 of 1